HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 288 filers reported holding HAEMONETICS CORP in Q4 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $417,000 | -58.7% | 6,591 | -65.4% | 0.00% | -33.3% |
| Q4 2021 | $1,010,000 | +221.7% | 19,048 | +304.7% | 0.00% | +200.0% |
| Q2 2021 | $314,000 | -86.6% | 4,707 | -77.7% | 0.00% | -92.9% |
| Q1 2021 | $2,339,000 | +107.4% | 21,072 | +121.9% | 0.01% | +75.0% |
| Q4 2020 | $1,128,000 | -53.7% | 9,498 | -65.9% | 0.01% | -75.8% |
| Q3 2020 | $2,434,000 | -72.1% | 27,893 | -71.4% | 0.03% | -76.6% |
| Q2 2020 | $8,723,000 | +110.3% | 97,393 | +134.0% | 0.14% | +33.0% |
| Q1 2020 | $4,148,000 | +103.7% | 41,625 | +134.9% | 0.11% | +783.3% |
| Q4 2019 | $2,036,000 | -18.3% | 17,721 | -14.4% | 0.01% | -50.0% |
| Q2 2019 | $2,492,000 | +1127.6% | 20,705 | +920.5% | 0.02% | +1100.0% |
| Q4 2018 | $203,000 | -95.5% | 2,029 | -96.0% | 0.00% | -96.7% |
| Q2 2018 | $4,515,000 | +2102.4% | 50,342 | +1327.7% | 0.06% | +1400.0% |
| Q4 2017 | $205,000 | -69.0% | 3,526 | -76.1% | 0.00% | -69.2% |
| Q3 2017 | $662,000 | – | 14,754 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |